Saturday, February 03, 2018 10:32:37 PM
. The French pharmaceutical firm Sanofi (NASDAQ: GCVRZ) is one of the companies playing the medical marijuana long-game. As a titan with an epic market cap of almost $124 billion, Sanofi is waiting around to scoop up the cannabis research and development companies once they hit that high. Their current research, involving a wide range of diseases and disorders, focuses on multiple sclerosis and other neurodegenerative diseases which can greatly benefit from cannabinoid-based medicines.
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM